# RESERPINE AND HYDROCHLOROTHIAZIDE
> **ANDA088200** · Abbreviated New Drug Application (Generic) · Sponsor: SANDOZ · Approved 1984-05-01
## Drug
- **FDA Application Number:** ANDA088200
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** RESERPINE AND HYDROCHLOROTHIAZIDE
- **Generic name:** Hydrochlorothiazide
- **Active ingredients:** HYDROCHLOROTHIAZIDE; RESERPINE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** SANDOZ
- **First approval:** 1984-05-01
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=088200)
---
*AI Analytics · CC0 1.0*